Jerry Gurwitz to Drug Therapy
This is a "connection" page, showing publications Jerry Gurwitz has written about Drug Therapy.
Connection Strength
0.728
-
Gurwitz JH. The age/gender interface in geriatric pharmacotherapy. J Womens Health (Larchmt). 2005 Jan-Feb; 14(1):68-72.
Score: 0.233
-
Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, Cadoret C, Fish LS, Garber L, Kelleher M, Bates DW. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
Score: 0.206
-
Thomson MS, Gruneir A, Lee M, Baril J, Field TS, Gurwitz JH, Rochon PA. Nursing time devoted to medication administration in long-term care: clinical, safety, and resource implications. J Am Geriatr Soc. 2009 Feb; 57(2):266-72.
Score: 0.077
-
Pierre-Jacques M, Safran DG, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Rusinak D, Soumerai SB. Reliability of new measures of cost-related medication nonadherence. Med Care. 2008 Apr; 46(4):444-8.
Score: 0.073
-
Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, Adler G, Safran DG. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006 Sep 25; 166(17):1829-35.
Score: 0.066
-
Andrade SE, Gurwitz JH, Davis RL, Chan KA, Finkelstein JA, Fortman K, McPhillips H, Raebel MA, Roblin D, Smith DH, Yood MU, Morse AN, Platt R. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004 Aug; 191(2):398-407.
Score: 0.057
-
Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R. Trends and outcomes associated with angiotensin-converting enzyme inhibitors. Am J Med. 2006 Jul; 119(7):616.e9-16.
Score: 0.016